Gyre Therapeutics (GYRE) Capital Expenditures (2010 - 2026)
Gyre Therapeutics (GYRE) reported Capital Expenditures of $178000.0 for Q1 2026, up 45.9% year-over-year from $122000.0 in Q1 2025, and up 23.61% on a QoQ basis from $144000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 15 years of Capital Expenditures data on file, last reported at $178000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 45.9% year-over-year to $178000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 43.52% YoY) and the FY2025 annual result came in at $1.2 million, down 48.6% from the prior year.
- Capital Expenditures climbed to $178000.0 in Q1 2026 per GYRE's latest filing, from $144000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.5 million in Q2 2023 and bottomed at -$65000.0 in Q4 2024.
- The 4-year median for Capital Expenditures is $668000.0 (2025), against an average of $938461.5.
- The widest annual swing landed in 2024, when Capital Expenditures tumbled 102.8%; it then soared 321.54% in 2025.
- Tracing GYRE's Capital Expenditures over 4 years: stood at $2.3 million in 2023, then plunged by 102.8% to -$65000.0 in 2024, then soared by 321.54% to $144000.0 in 2025, then gained by 23.61% to $178000.0 in 2026.
- Per Business Quant, the three latest GYRE Capital Expenditures figures stand at $178000.0 (Q1 2026), $144000.0 (Q4 2025), and $668000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 178,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178,000.00 |
| Mar 31, 2026 | 178,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 668,000.00 |
| Sep 30, 2025 | 668,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | 693,000.00 |
| Sep 30, 2024 | 693,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 231,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 2.32 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Sep 30, 2021 | 492,000.00 |
| Sep 30, 2021 | 492,000.00 |
| Sep 30, 2020 | 195,000.00 |
| Sep 30, 2020 | 195,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | 49,000.00 |
| Jun 30, 2019 | 49,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | 175,000.00 |
| Dec 31, 2018 | 175,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 198,000.00 |
| Mar 31, 2018 | 198,000.00 |
| Dec 31, 2017 | 20,000.00 |
| Dec 31, 2017 | 20,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Dec 31, 2016 | 122,000.00 |
| Dec 31, 2016 | 122,000.00 |
| Sep 30, 2016 | 22,000.00 |
| Sep 30, 2016 | 22,000.00 |
| Jun 30, 2016 | 235,000.00 |
| Jun 30, 2016 | 235,000.00 |
| Mar 31, 2016 | 89,000.00 |
| Mar 31, 2016 | 89,000.00 |
| Dec 31, 2015 | 98,000.00 |
| Dec 31, 2015 | 98,000.00 |
| Dec 31, 2013 | -51,000.00 |
| Dec 31, 2013 | -51,000.00 |
| Jun 30, 2013 | 22,000.00 |
| Jun 30, 2013 | 22,000.00 |
| Mar 31, 2013 | 70,000.00 |
| Mar 31, 2013 | 70,000.00 |
| Dec 31, 2012 | 195,000.00 |
| Dec 31, 2012 | 195,000.00 |
| Sep 30, 2012 | 1,000.00 |
| Sep 30, 2012 | 1,000.00 |
| Jun 30, 2012 | 91,000.00 |
| Jun 30, 2012 | 91,000.00 |
| Mar 31, 2012 | 46,000.00 |
| Mar 31, 2012 | 46,000.00 |
| Dec 31, 2011 | 252,000.00 |
| Dec 31, 2011 | 252,000.00 |
| Sep 30, 2011 | 167,000.00 |
| Sep 30, 2011 | 167,000.00 |
| Jun 30, 2011 | 414,000.00 |
| Jun 30, 2011 | 414,000.00 |
| Mar 31, 2011 | 598,000.00 |
| Mar 31, 2011 | 598,000.00 |
| Dec 31, 2010 | 1.61 Mn |
| Dec 31, 2010 | 1.61 Mn |
| Sep 30, 2010 | 197,000.00 |
| Sep 30, 2010 | 197,000.00 |